tiprankstipranks
Trending News
More News >

Shanghai Haohai Biological Technology Faces Shareholder Investigation

Story Highlights
Shanghai Haohai Biological Technology Faces Shareholder Investigation

Don’t Miss TipRanks’ Half-Year Sale

Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has provided an announcement.

Shanghai Haohai Biological Technology Co., Ltd. announced that one of its controlling shareholders, Mr. Jiang Wei, has been notified by the China Securities Regulatory Commission (CSRC) regarding a case filing for suspected insider trading. The company clarified that this investigation is personal to Mr. Jiang Wei and does not involve the company’s shares or affect its daily operations. The company will continue to monitor the situation and fulfill its disclosure obligations.

More about Shanghai Haohai Biological Technology Co., Ltd. Class H

Shanghai Haohai Biological Technology Co., Ltd. is a joint stock company incorporated in China, focusing on the biotechnology sector. The company is listed on the Hong Kong Stock Exchange and is involved in the development and production of biological products.

Average Trading Volume: 579,936

Technical Sentiment Signal: Sell

Current Market Cap: HK$12.09B

Find detailed analytics on 6826 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1